BRPI0407636A - meio de cultura de células, linhagem de células animais, métodos para produzir um meio de cultura condicionado, células animais, uma cultura de células animais, vìrus em uma cultura de células animais, ou, de preferência, humanas diplóides dependentes de ancoragem, método para produzir uma vacina, e, população de vìrus - Google Patents
meio de cultura de células, linhagem de células animais, métodos para produzir um meio de cultura condicionado, células animais, uma cultura de células animais, vìrus em uma cultura de células animais, ou, de preferência, humanas diplóides dependentes de ancoragem, método para produzir uma vacina, e, população de vìrusInfo
- Publication number
- BRPI0407636A BRPI0407636A BRPI0407636-2A BRPI0407636A BRPI0407636A BR PI0407636 A BRPI0407636 A BR PI0407636A BR PI0407636 A BRPI0407636 A BR PI0407636A BR PI0407636 A BRPI0407636 A BR PI0407636A
- Authority
- BR
- Brazil
- Prior art keywords
- animal
- cell culture
- virus
- culture medium
- animal cell
- Prior art date
Links
- 210000004102 animal cell Anatomy 0.000 title abstract 9
- 238000000034 method Methods 0.000 title abstract 7
- 241000700605 Viruses Species 0.000 title abstract 6
- 238000004113 cell culture Methods 0.000 title abstract 3
- 239000006143 cell culture medium Substances 0.000 title abstract 3
- 230000001419 dependent effect Effects 0.000 title abstract 3
- 239000003636 conditioned culture medium Substances 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 5
- 210000004027 cell Anatomy 0.000 abstract 3
- 238000012258 culturing Methods 0.000 abstract 2
- 102000004142 Trypsin Human genes 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
- 229960004854 viral vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32451—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0304799.0A GB0304799D0 (en) | 2003-03-03 | 2003-03-03 | Novel method |
| PCT/EP2004/002067 WO2004078955A1 (en) | 2003-03-03 | 2004-03-01 | Animal-free cell culture method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0407636A true BRPI0407636A (pt) | 2006-02-21 |
Family
ID=9953995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0407636-2A BRPI0407636A (pt) | 2003-03-03 | 2004-03-01 | meio de cultura de células, linhagem de células animais, métodos para produzir um meio de cultura condicionado, células animais, uma cultura de células animais, vìrus em uma cultura de células animais, ou, de preferência, humanas diplóides dependentes de ancoragem, método para produzir uma vacina, e, população de vìrus |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8034617B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP2186885A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4787739B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101242090B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN101200705A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004217807B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0407636A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2517327A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO5601047A2 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0304799D0 (cg-RX-API-DMAC7.html) |
| IS (1) | IS7992A (cg-RX-API-DMAC7.html) |
| MA (1) | MA27631A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05009096A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20054124L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ541908A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2369634C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004078955A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2335650B1 (en) | 2003-12-11 | 2012-10-03 | Isto Technologies Inc. | Particulate cartilage system |
| JP4650798B2 (ja) * | 2004-04-19 | 2011-03-16 | デンカ生研株式会社 | ウイルスの生産方法 |
| EP1812557A4 (en) * | 2004-10-29 | 2009-11-04 | Centocor Ortho Biotech Inc | COMPOSITIONS OF CHEMICALLY DEFINED MEDIA |
| WO2006095431A1 (ja) * | 2005-03-10 | 2006-09-14 | Kyoritsu Seiyaku Corporation | 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法 |
| EP1891207A2 (en) * | 2005-06-03 | 2008-02-27 | Biovitrum AB | Process for cultivating animal cells comprising the feeding of plant-derived peptones |
| JP5292533B2 (ja) | 2005-08-26 | 2013-09-18 | ジンマー・インコーポレイテッド | インプラントおよび関節疾患の治療、置換および治療方法 |
| EP1764117A1 (en) | 2005-09-20 | 2007-03-21 | Zimmer GmbH | Implant for the repair of a cartilage defect and method for manufacturing the implant |
| US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
| EP2134297B1 (en) | 2007-04-12 | 2017-03-08 | Zimmer, Inc. | Apparatus for tissue repair |
| FI20075417A0 (fi) * | 2007-06-05 | 2007-06-05 | Marjo-Riitta Suuronen | Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen |
| DK2250251T3 (en) | 2008-01-09 | 2018-01-22 | Sartorius Stedim Cellca Gmbh | Improved culture medium additive and method of using it |
| NZ700477A (en) | 2009-02-17 | 2016-04-29 | Glaxosmithkline Biolog Sa | Inactivated dengue virus vaccine with aluminium-free adjuvant |
| AU2011246503B2 (en) | 2010-04-26 | 2013-09-26 | Novartis Ag | Improved cell culture medium |
| CN101831415B (zh) * | 2010-05-12 | 2012-05-30 | 江苏博立生物制品有限公司 | 一种提高糖化酶发酵水平的方法 |
| EP2681306B1 (en) * | 2011-02-28 | 2019-01-09 | President and Fellows of Harvard College | Cell culture system |
| WO2013084190A1 (en) | 2011-12-08 | 2013-06-13 | Yeda Research And Development Co. Ltd. | Mammalian fetal pulmonary cells and therapeutic use of same |
| US9493744B2 (en) * | 2012-06-20 | 2016-11-15 | Genentech, Inc. | Methods for viral inactivation and other adventitious agents |
| US20130281355A1 (en) * | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
| JP6041199B2 (ja) * | 2012-09-14 | 2016-12-07 | 国立大学法人大阪大学 | 三次元細胞培養体の製造方法 |
| US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
| ES3063334T3 (en) | 2015-06-18 | 2026-04-16 | Yeda Res & Dev | Conditioning protocols and use of same for tissue regeneration |
| US10004795B2 (en) * | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
| BE1024160B9 (fr) | 2015-12-22 | 2017-12-06 | Glaxosmithkline Biologicals Sa | Formulation immunogène |
| CN105567628B (zh) * | 2016-01-30 | 2019-07-12 | 令世鑫 | 一种全悬浮培养mdck细胞的低血清培养基 |
| CN105695393B (zh) * | 2016-03-24 | 2019-09-10 | 友康恒业生物科技(北京)有限公司 | 一种mdck细胞无血清培养基及其用途和制备 |
| CN105779376B (zh) * | 2016-03-24 | 2019-08-30 | 友康恒业生物科技(北京)有限公司 | 一种流感病毒分离无血清培养基及其用途和制备 |
| KR101925079B1 (ko) * | 2017-05-24 | 2018-12-04 | 가천대학교 산학협력단 | Dna 정제-증폭을 위한 통합형 마이크로 디바이스 및 이를 이용한 dna 정제-증폭 방법 |
| CN107432931B (zh) * | 2017-08-03 | 2018-04-13 | 长春祈健生物制品有限公司 | 一种微载体培养水痘病毒制备疫苗的方法 |
| MX2021006115A (es) * | 2019-01-17 | 2021-07-07 | Boehringer Ingelheim Animal Health Usa Inc | Medio libre de suero para produccion de vacuna aviar y usos del mismo. |
| MX2022008144A (es) | 2019-12-31 | 2022-08-17 | Air Protein Inc | Composiciones alimenticias con alto contenido de proteinas. |
| WO2021151025A1 (en) * | 2020-01-24 | 2021-07-29 | Air Protein, Inc. | Microorganism-derived protein hydrolysates, and methods of preparation and use thereof |
| MX2022010931A (es) | 2020-03-02 | 2022-09-29 | Air Protein Inc | Composiciones estructuradas analogas a la carne con alto contenido de proteinas. |
| CN113373107B (zh) * | 2021-01-29 | 2022-12-30 | 上海生物制品研究所有限责任公司 | 一种大规模制备传代鸡胚细胞生产病毒的方法 |
| WO2024039216A1 (ko) * | 2022-08-19 | 2024-02-22 | 셀미트주식회사 | 동물세포 또는 동물 세포주의 배양방법 |
| CN115627255B (zh) * | 2022-12-01 | 2023-04-07 | 天信和(苏州)生物科技有限公司 | 一种采用低血清培养基培养人二倍体细胞的方法 |
| KR102926380B1 (ko) * | 2025-02-19 | 2026-02-12 | (주)엑셀세라퓨틱스 | 줄기세포 유래 엑소좀의 제조방법, 엑소좀 및 이를 포함하는 조성물 |
| CN119979445B (zh) * | 2025-04-10 | 2025-09-09 | 四川大学 | 一种培养基、口腔黏膜上皮细胞模型,及其制备方法和用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2018228C (en) | 1989-06-05 | 1996-02-27 | Nancy L. Parenteau | Cell culture systems and media |
| GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| DE4115722A1 (de) | 1991-05-14 | 1992-11-19 | Boehringer Mannheim Gmbh | Serumfreies medium zur kultivierung von saeugerzellen |
| RU2057176C1 (ru) * | 1992-05-20 | 1996-03-27 | Институт генетики АН Республики Молдова | Питательная среда для культивирования клеток человека и животных |
| DZ1706A1 (fr) * | 1992-08-07 | 2002-02-17 | Merck & Co Inc | Vaccin contre le virus de l'hepatite a. |
| US6180110B1 (en) | 1992-09-18 | 2001-01-30 | The United States Of America As Represented By The Department Of Health And Human Services | Attenuated hepatitis a virus vaccine which grows in MRC-5 cells |
| CN1088984A (zh) * | 1993-11-11 | 1994-07-06 | 江西省医学科学研究所 | 一种用于造血祖细胞培养的无血清培养基 |
| HRP950097A2 (en) | 1994-03-08 | 1997-06-30 | Merck & Co Inc | Hepatitis a virus culture process |
| ATE542891T1 (de) | 1994-11-10 | 2012-02-15 | Baxter Healthcare Sa | Verfahren zur herstellung von biologischen produkten in protein-freier kultur |
| WO1998000521A1 (fr) * | 1996-06-28 | 1998-01-08 | The Green Cross Corporation | Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives |
| WO1998004680A1 (en) * | 1996-07-26 | 1998-02-05 | University Of Manitoba | Serum-free medium for growth of anchorage-dependant mammalian cells |
| US6103529A (en) * | 1996-10-10 | 2000-08-15 | Life Technologies, Inc. | Animal cell culture media comprising peptides derived from rice |
| AU7984498A (en) * | 1997-06-25 | 1999-01-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Serum-free cell growth medium |
| US6656719B1 (en) * | 1997-10-27 | 2003-12-02 | Merck & Co., Inc. | Serum-free, low-protein media for rotavirus vaccine production |
| FR2775983B1 (fr) | 1998-03-13 | 2000-11-10 | Pasteur Merieux Serums Vacc | Milieu et procede de propagation et de multiplication virales |
| WO1999057246A1 (en) * | 1998-05-01 | 1999-11-11 | Life Technologies, Inc. | Animal cell culture media comprising non-animal or plant-derived nutrients |
| US6406909B1 (en) * | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| US6623959B2 (en) * | 2001-06-13 | 2003-09-23 | Ethicon, Inc. | Devices and methods for cell harvesting |
-
2003
- 2003-03-03 GB GBGB0304799.0A patent/GB0304799D0/en not_active Ceased
-
2004
- 2004-03-01 CA CA002517327A patent/CA2517327A1/en not_active Abandoned
- 2004-03-01 RU RU2005125606/13A patent/RU2369634C2/ru not_active IP Right Cessation
- 2004-03-01 US US10/547,804 patent/US8034617B2/en not_active Expired - Fee Related
- 2004-03-01 EP EP10151350A patent/EP2186885A1/en not_active Withdrawn
- 2004-03-01 BR BRPI0407636-2A patent/BRPI0407636A/pt not_active IP Right Cessation
- 2004-03-01 KR KR1020057016385A patent/KR101242090B1/ko not_active Expired - Fee Related
- 2004-03-01 NZ NZ541908A patent/NZ541908A/en unknown
- 2004-03-01 AU AU2004217807A patent/AU2004217807B2/en not_active Ceased
- 2004-03-01 EP EP04715891A patent/EP1599580A1/en not_active Ceased
- 2004-03-01 EP EP10151351A patent/EP2192175A1/en not_active Ceased
- 2004-03-01 MX MXPA05009096A patent/MXPA05009096A/es active IP Right Grant
- 2004-03-01 WO PCT/EP2004/002067 patent/WO2004078955A1/en not_active Ceased
- 2004-03-01 JP JP2006504501A patent/JP4787739B2/ja not_active Expired - Fee Related
- 2004-03-01 CN CNA2007101866779A patent/CN101200705A/zh active Pending
- 2004-03-01 CN CN2004800058488A patent/CN1756837B/zh not_active Expired - Fee Related
-
2005
- 2005-08-18 IS IS7992A patent/IS7992A/is unknown
- 2005-08-31 CO CO05087280A patent/CO5601047A2/es not_active Application Discontinuation
- 2005-09-05 NO NO20054124A patent/NO20054124L/no not_active Application Discontinuation
- 2005-09-09 MA MA28488A patent/MA27631A1/fr unknown
-
2010
- 2010-07-12 JP JP2010157682A patent/JP2010273683A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050105509A (ko) | 2005-11-04 |
| NO20054124D0 (no) | 2005-09-05 |
| MXPA05009096A (es) | 2005-10-19 |
| JP2010273683A (ja) | 2010-12-09 |
| AU2004217807B2 (en) | 2009-06-25 |
| US8034617B2 (en) | 2011-10-11 |
| RU2005125606A (ru) | 2006-03-10 |
| MA27631A1 (fr) | 2005-11-01 |
| CN1756837A (zh) | 2006-04-05 |
| CO5601047A2 (es) | 2006-01-31 |
| GB0304799D0 (en) | 2003-04-09 |
| NO20054124L (no) | 2005-09-27 |
| JP4787739B2 (ja) | 2011-10-05 |
| KR101242090B1 (ko) | 2013-03-08 |
| EP2192175A1 (en) | 2010-06-02 |
| CN1756837B (zh) | 2010-05-26 |
| RU2369634C2 (ru) | 2009-10-10 |
| AU2004217807A1 (en) | 2004-09-16 |
| US20060183224A1 (en) | 2006-08-17 |
| EP1599580A1 (en) | 2005-11-30 |
| JP2006519023A (ja) | 2006-08-24 |
| CA2517327A1 (en) | 2004-09-16 |
| WO2004078955A1 (en) | 2004-09-16 |
| NZ541908A (en) | 2008-04-30 |
| IS7992A (is) | 2005-08-18 |
| EP2186885A1 (en) | 2010-05-19 |
| CN101200705A (zh) | 2008-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05009096A (es) | Metodo de cultivo celular libre de animal. | |
| ATE482267T1 (de) | Tierzellen und verfahren für die replikation von influenza viren | |
| FR08C0046I2 (fr) | Reconstitution in vitro de virus a arn de polarite negative segmentes | |
| BRPI0506474A (pt) | sistema de tecido com células tronco não diferenciadas derivadas no limbus da córnea | |
| PT1526172E (pt) | Processo para a replicação de vírus influenza em cultura celular e os vírus influenza que podem ser obtidos pelo processo | |
| BR0212469A (pt) | Método para multiplicação de vìrus em cultura de célula | |
| DK1201749T3 (da) | Fremgangsmåde til fremstilling af humane bruskimplantater ved hjælp af in vitro dyrkede chondrocytter | |
| ATE289348T1 (de) | Methoden zur erhöhung der produktion von viralen impstoffen in zellkultur durch unterdrückung von interferon | |
| DE122011000005I1 (de) | Verfahren zur grosstechnischen herstellung von impfstoffen | |
| BR0210599A (pt) | Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril | |
| ES2139553T1 (es) | Replicacion de virus de la gripe en un cultivo de celulas de mamiferos y produccion de vacuna. | |
| BR112022014305A2 (pt) | Uso de homólogos de proteínas de plantas em meios de cultura | |
| DE69626022D1 (de) | Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff | |
| WO2005115448A3 (en) | Multi plasmid system for the production of influenza virus | |
| NO20032097D0 (no) | Gj¶ravledet vaksine mot IPNV | |
| ES8202357A1 (es) | Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados | |
| NO912621L (no) | Fremgangsmaate for innfoering av dna i animalske celler. | |
| Scherer et al. | Studies on the Propagation in Vitro of Poliomyelitis Viruses: III. The Propagation of Poliomyelitis Viruses in Tissue Cultures Devoid of Nerve Cells | |
| DE60334372D1 (de) | Verfahren zur herstellung von gewebekonstrukten | |
| BR0002694A (pt) | Processo de obtenção de vacina contra raiva em células vero, para uso humano | |
| UA6132U (en) | Liquid cultural inactivated vaccine against aueski disease in pigs, sheep, and fur-bearing animals | |
| CA2250714A1 (en) | Animal cells and processes for the replication of influenza viruses | |
| BR0112388A (pt) | Meios econÈmicos para cultura de célula de inseto em larga escala |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C12N 5/06 , C12N 7/02 Ipc: C12N 5/06 (2010.01), C12N 7/02 (2006.01), A61K 39/ |
|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: C12N 7/00 (2006.01), C12N 5/00 (2006.01) |